Eric R Arnson Net Worth

The estimated Net Worth of Eric R Arnson is at least 31.5 百万$ dollars as of 8 December 2017. Eric Arnson owns over 994,000 units of Tabula Rasa HealthCare Inc stock worth over 5,848,175$ and over the last 8 years Eric sold TRHC stock worth over 25,694,900$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Eric Arnson TRHC stock SEC Form 4 insiders trading

Eric has made over 2 trades of the Tabula Rasa HealthCare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Eric sold 994,000 units of TRHC stock worth 25,694,900$ on 8 December 2017.

The largest trade Eric's ever made was selling 994,000 units of Tabula Rasa HealthCare Inc stock on 8 December 2017 worth over 25,694,900$. On average, Eric trades about 500,750 units every 215 days since 2016. As of 8 December 2017 Eric still owns at least 556,969 units of Tabula Rasa HealthCare Inc stock.

You can see the complete history of Eric Arnson stock trades at the bottom of the page.

What's Eric Arnson's mailing address?

Eric's mailing address filed with the SEC is 205 Webster St, Bethlehem, PA 18015, USA.

Insiders trading at Tabula Rasa HealthCare Inc

Over the last 8 years, insiders at Tabula Rasa HealthCare Inc have traded over 245,667,405$ worth of Tabula Rasa HealthCare Inc stock and bought 1,486,398 units worth 7,620,320$ . The most active insiders traders include Calvin H Knowlton、Orsula V Knowlton、Capital Management, L.P.Ic .... On average, Tabula Rasa HealthCare Inc executives and independent directors trade stock every 8 days with the average trade being worth of 441,116$. The most recent stock trade was executed by Michael Greenhalgh on 28 June 2023, trading 25,000 units of TRHC stock currently worth 77,750$.

What does Tabula Rasa HealthCare Inc do?

the tabula rasa healthcare family of companies provide new beginnings for our clients, through innovative service models and fresh approaches to healthcare technology. our leaders understand that to maximize patient experiences and outcomes, they must help providers to balance efficiency and scalability with safety and individualization of care.

Complete history of Eric Arnson stock trades at Tabula Rasa HealthCare Inc

Tabula Rasa HealthCare Inc executives and stock owners

Tabula Rasa HealthCare Inc executives and other stock owners filed with the SEC include:

• Calvin Knowlton,
  Chairman of the Board, Chief Executive Officer, Co-Founder
• Orsula Knowlton,
  President, Co-Founder, Chief Marketing Officer & New Business Development Officer, Director
• Brian Adams,
  Chief Financial Officer
• Pamela Schweitzer,
  Independent Director
• Dr. Calvin H. Knowlton BSc Pharm, MDiv, Ph.D.,
  Co-Founder, Chairman & CEO
• A. Gordon Tunstall,
  Lead Independent Director
• Dr. Orsula Voltis Knowlton BScPharm, M.B.A., MBA, Pharm.D., PharmD,
  Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director
• Michael Greenhalgh,
  Chief Operating Officer
• Michael Purcell,
  Independent Director
• Samira Beckwith,
  Independent Director
• Dennis Helling,
  Independent Director
• Jan Berger,
  Independent Director
• Kathrine O'Brien,
  Independent Director
• Frank Sparacino,
  IR Contact Officer
• Jeffrey DiFrancesco,
  Chief Product Officer
• Bob Sullivan,
  Chief Technology Officer
• Steve Lemak,
  Senior Vice President - IT Infrastructure, CareVention HealthCare Division
• Michael Greenhalgh,
  Co-Founder, Chief Operating Officer
• Frank Sparacino C.F.A., CPA,
  Sr. VP of Investor Relations & Corp. Devel.
• Phillip W. Heath MS,
  Chief Admin. Officer
• Dr. Jacques Turgeon B.Pharm., Ph.D.,
  Chief Scientific Officer & CEO of TRHC Precision Pharmacotherapy, R&D Institute
• Joseph J. Filippoli,
  Chief Information Officer
• Bob Sullivan M.S.,
  Chief Technology Officer
• Andrea Carolan Speers M.S.,
  Corp. Controller & Chief Accounting Officer
• Bruce Luehrs,
  Director
• Venture Partners Iii, Llcra...,
  
• Eric R Arnson,
  10% owner
• Growth Fund 1 Q Lpbressner ...,
  
• Daniel C Lubin,
  Director
• Michael J Gausling,
  10% owner
• Glen R Bressner,
  Director
• Growth Fund 1 A Lpbressner ...,
  
• Joann M. Durham,
  10% owner
• John R. Durham,
  10% owner
• Growth Fund 1 A Lp Originat...,
  
• Stage2 Ventures, L.P.Stage2...,
  
• Growth Fund 1 Q Lp Originat...,
  
• Michael Anthony Bruno,
  CHIEF ACCOUNTING OFFICER
• Ronald Paul Mitchell,
  
• Thomas Cancro,
  CHIEF FINANCIAL OFFICER
• Richard W. Ii Rew,
  CHIEF LEGAL OFFICER, SECRETARY
• Jonathan David Schwartz,
  
• Capital Management, L.P.Ic ...,
  
• Capital Management, L.P.Ic ...,
  
• Capital Management, L.P.Ind...,